These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21767992)

  • 1. The impact of federal warnings on publically funded desmopressin utilization among children in Ontario.
    Gomes T; Juurlink DN; Moore I; Maguire JL; Mamdani MM
    J Pediatr Urol; 2012 Jun; 8(3):249-53. PubMed ID: 21767992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irish Medicines Board safety warnings: do they affect prescribing rates in primary care?
    Musleh S; Kraus S; Bennett K; Zaharan NL
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):979-86. PubMed ID: 21774032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone.
    Stewart KA; Natzke BM; Williams T; Granger E; Casscells SW; Croghan TW
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1048-52. PubMed ID: 19655338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction.
    De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
    J Urol; 2011 Jun; 185(6):2308-13. PubMed ID: 21511277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriber compliance with black box warnings in older adult patients.
    Ricci JR; Coulen C; Berger JE; Moore MC; McQueen A; Jan SA
    Am J Manag Care; 2009 Nov; 15(11):e103-8. PubMed ID: 19895180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
    Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
    Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
    Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
    Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.
    Katz LY; Kozyrskyj AL; Prior HJ; Enns MW; Cox BJ; Sareen J
    CMAJ; 2008 Apr; 178(8):1005-11. PubMed ID: 18390943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Did the removal of the indication of nocturnal enuresis for intranasal desmopressin change prescribing practice?
    Hoffmann F; Glaeske G; Steuber C
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):105-9. PubMed ID: 21182158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
    Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
    BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria.
    Chang YL; Lin AT; Chen KK
    J Urol; 2007 Jun; 177(6):2227-9; discussion 2230. PubMed ID: 17509326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
    Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight testing of renal concentrating capacity in children using desmopressin tablets: sensitivity, repeatability and non-inferiority versus intranasal spray.
    Asa Rembratt ; Jens-Kristian Jensen ; Kjell Tullus ; Staffan Mårild ;
    Scand J Urol Nephrol; 2008; 42(3):274-7. PubMed ID: 17943639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioequivalence study of two oral desmopressin tablet formulations.
    Kaehler ST; Steiner IM; Sauermann R; Scheidl H; Mueller M; Joukhadar C
    Pharmacology; 2006; 77(1):46-52. PubMed ID: 16651830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of desmopressin on short-term memory in children with primary nocturnal enuresis.
    Müller D; Florkowski H; Chavez-Kattau K; Carlsson G; Eggert P
    J Urol; 2001 Dec; 166(6):2432-4. PubMed ID: 11696805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a fluoroquinolone restriction policy in an elderly population.
    Mamdani M; McNeely D; Evans G; Hux J; Oh P; Forde N; Conly J
    Am J Med; 2007 Oct; 120(10):893-900. PubMed ID: 17904461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.